Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 3 records per page: next > | last >>
pages: 1 2 3 presentations: 1 to 25 of 71
Crystal Structure of Parathyroid Hormone 1 Receptor in Complex With a Peptide Agonist
Christoph Klenk, MD, PhD
University of Zurich, Zurich, Switzerland
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
PTH Receptor Ligands Using Nanobodies for CLAMPing
Ross Cheloha, PhD
NIH, Bethesda, MD
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
GPCR Signaling in Membrane Lipid Environment
Isabel Alves, PhD
Universite de Bordeaux, Pessac, France
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Chemogenetics of GPCR Signaling
Graeme Milligan, PhD
University of Glasgow, Glasgow, United Kingdom
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Abstract Presentation: Inhibition of CXCR2 by Glucocorticoids in Adipose Tissue
Shripa Amatya, MS
Louisiana State University Health Sciences Center, Shreveport, LA
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Membrane Androgen Receptors in Neurodegeneration
Rebecca Cunningham, PhD
The University of North Texas Health Science Center, Fort Worth, TX
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Membrane Androgen Receptors in the Reproductive System
Peter Thomas, PhD
The University of Texas at Austin, Port Aransas, TX
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Progesterone Receptor Membrane Component (PGRMC) 1 and PGRMC2 in Female Reproductive Physiology
James Pru, PhD
Washington State University, Pullman, WA
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Abstract Presentation: A Novel Role of Nuclear and Membrane Receptor on Isoflavone-Induced Neuritogenesis and Synaptogenesis
Winda Ariyani, PhD
Gunma University, Maebashi, Japan
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Exploiting How Membrane Receptors Signal Inside Cells: Example of c-MET
Stéphanie Kermorgant, PhD
Barts Cancer Institute, Queen Mary University London, London, United Kingdom
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Abstract Presentation: Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer
Thu Truong, PhD
University of Minnesota, Minneapolis, MN
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
Chair
Jennifer Adibi, MPH, SCD
University of Pittsburgh, Pittsburgh, PA
Abstract Presentation: Human Placenta MicroRNA Differences Between First and Third Trimester
Tania Gonzalez, PhD
Cedars-Sinai Medical Center, Los Angeles, CA
Live Moderated Q&A and Session Closing
Chair
Robert Taylor, MD, PhD
University at Buffalo, Jacobs School of Medicine, Buffalo, NY
Welcome and Introductions
Endometrial Extracellular Vesicles and Implantation
Felipe Vilella, PhD
Igenomix Foundation, Instituto de Investigacion Sanitaria, Valencia, Spain
Live Moderated Q&A
Pregnancy Communication: Exploring Extracellular Vesicles
Virginia Winn, MD, PhD
Stanford University, Stanford, CA
Live Moderated Q&A
Key Considerations Relating to exRNA Isolation for Biomarker Discovery
Louise Laurent, MD, PhD
University of California, San Diego, La Jolla, CA
Live Moderated Q&A
from ENDO 2021 on March 21, 2021 12:15 PM-1:45 PM
Chair
Johnson Thomas, MD
Mercy Hospital, Springfield, MO
Chair
Daniel Frigo, PhD
University of Texas MD Anderson Cancer Center, Houston, TX
Welcome and Introductions
Deep Learning-Enabled Computational Microscopy
Aydogan Ozcan, PhD
University of California, Los Angeles, Los Angeles, CA
Live Moderated Q&A
Deep Learning, Gaming and Crowd Science to Improve Large-Scale Image Classification
Emma Lundberg, PhD
Science for Life Laboratory, Stockholm, Sweden
Live Moderated Q&A
Artificial Intelligence in Endocrine Related Tumors
Johnson Thomas, MD, FACE
Mercy Hospital, Springfield, MO
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 21, 2021 3:15 PM-4:45 PM
Chair
Ali Abbara, PhD
Imperial College London, London, United Kingdom
Chair
Ursula Kaiser, MD
Brigham and Women's Hospital, Boston, MA
Welcome and Introductions
Introduction to Novel Neuropeptides in Reproductive Axis Regulation
Sasha Howard, MBBS, PhD
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom
Live Moderated Q&A
Discovery and Introduction to Phoenixin
Gina Yosten, PhD
Saint Louis University, Saint Louis, MO
Live Moderated Q&A
Regulation of Phoenixin and Spexin by Fatty Acids, Nitric Oxide and the Endocrine-Disrupting Chemical BPA: Molecular Analysis
Denise Belsham, PhD
University of Toronto, Toronto, ON, Canada
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 23, 2021 12:15 PM-1:45 PM
Chair
Kim Jonas, PhD, BSc, PGCert
King's College London, London, United Kingdom
FGF-2-Dependent Signaling Activated in Aged Human Skeletal Muscle Promotes Intramuscular Adipogenesis
Sebastian Mathes, MSc
University Hospital Zurich, Zurich, Switzerland
Audience Q&A
Human GPR17 Nonsynonymous Variants Identified in Individuals with Metabolic Diseases Have Distinct Functional Signaling Profiles
Jason Conley, PhD
Indiana University School of Medicine, Indianapolis, IN
Audience Q&A
Dapagliflozin Exerts Adrenal Sympatholysis via G protein-Coupled Receptor Kinase-2 & Tyrosine Hydroxylase Downregulation
Anastasios Lymperopoulos, PhD
Nova Southeastern University, Davie, FL
Audience Q&A
An Epigenomic Signature in Children Born Small for Gestational Age (SGA) With “Catch-up” Growth Is Present From Birth and Predicts Early Adulthood Pre-Hypertension
Terence Garner, MSc
University of Manchester, Manchester, United Kingdom
Audience Q&A
from ENDO 2021 on March 23, 2021 2:00 PM-3:00 PM
Chair
Davide Calebiro, MD, PhD
University of Birmingham, Birmingham, United Kingdom
Chair
Ursula Kaiser, MD
Brigham and Women's Hospital, Boston, MA
Welcome and Introductions
Pharmacogenomics of G Protein Coupled Receptors
M. Madan Babu, PhD
St. Jude Children's Research Hospital, Memphis, TN
Live Moderated Q&A
Using Genetic Associations as a Tool to Dissect GPCR Function in T2D
Rob Sladek, MD
McGill University, Montreal, QC, Canada
Live Moderated Q&A
T2D Associated With Melatonin Receptor 2
Ralf Jockers, PhD
Institut Cochin, Paris, France
Live Moderated Q&A and Session Closing
from ENDO 2021 on March 23, 2021 3:15 PM-4:45 PM
Chair
Hans H Zingg, MD,PHD
McGill Univ, Montreal, QC
from ENDO 2018 on March 18, 2018 4:00 PM-5:30 PM
Oxytocin and Stress
Robert J Handa, PHD
Colorado State Univ, Fort Collins, CO
from ENDO 2018 on March 18, 2018 4:00 PM-5:30 PM
Vasopressin and Falls & Fractures
Joseph G Verbalis, MD
Georgetown Univ, Washington, DC
from ENDO 2018 on March 18, 2018 4:00 PM-5:30 PM
Discovery and Function of Novel Neuropeptides and Peptide Hormones
James W Checco, PhD
University of Illinois at Urbana-Champaign, Urbana, IL
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Novel Neuropeptide GPCRs Implicated in Feeding and Obesity
Lakshmi A. Devi, Ph.D.
Mount Sinai School of Medicine, New York, NY
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Fatty Acid Receptors and Glucose Homeostasis
Stefan Offermanns, PhD
Max-Planck-Institut für Herz- und Lungenforschung, Bad Nauheim, Bad Nauheim, Germany
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
A Year in Progress in GPCR Research
Deborah L Segaloff, PhD
Univ of Iowa Carver Coll of Med, Iowa City, IA
from ENDO 2016 on April 1, 2016 12:15 PM-1:15 PM
(K/O Round) Lxrbeta Antagonism Mitigates Glucocorticoid-Induced Gluconeogenesis without Altering Immune Suppression
Rucha Patel, PhD
University of Toronto, Toronto, ON
from ENDO 2016 on April 2, 2016 10:00 AM-11:15 AM
(K/O Round) Exploring Biased G Protein-Coupled Receptor Agonism with Biophsyical Probes
Erik G. Strungs
Medical University of South Carolina, Charleston, SC
from ENDO 2016 on April 2, 2016 10:00 AM-11:15 AM
<< first | < prev page: of 3 records per page: next > | last >>
pages: 1 2 3 presentations: 1 to 25 of 71